Loại tài liệu:    Chỉ tìm trong: 
41-50 trong số 61 kết quả
NELBI score: a new clinical calculator of thirty-day mortality following systemic anticancer therapy in breast cancer patients near the end of life
Tác giả: Tuğba Önder, Cengiz Karaçin
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  011.52
 
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort
Tác giả: Daniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, Hadar Goldvaser, Ariel Hammerman, Daniel A Goldstein
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  546.752
 
Adjuvant chemotherapy in T1a/bN0 breast cancer with a high 21-gene recurrence score (> 25): a 10-year follow-up in a real-world cohort
Tác giả: Daniela Katz, Ilan Feldhamer, Yael Wolff-Sagy, Hadar Goldvaser, Ariel Hammerman, Daniel A Goldstein
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  155.6463
 
Prediction model for individualized precision surgery in breast cancer patients with complete response on MRI and residual calcifications on mammography after neoadjuvant chemotherapy
Tác giả: Mi-Ri Kwon, Ji Soo Choi, Boo-Kyung Han, Haejung Kim, Myoung Kyoung Kim, Eun Sook Ko, Eun Young Ko, Hyunwoo Lee, Jeong Eon Lee, Inyoung Youn, Jonghan Yu
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  553.3
 
A genome-wide CRISPR/Cas9 knockout screen identifies SEMA3F gene for resistance to cyclin-dependent kinase 4 and 6 inhibitors in breast cancer
Tác giả: Yuko Kawai, Tetsu Hayashida, Tomoe Kameyama, Yuko Kitagawa, Kazuhiro Miyao, Aiko Nagayama, Tomoko Seki, Maiko Takahashi, Makoto Takeuchi, Xinyue Wang, Takamichi Yokoe
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  001.944
 
Clinical outcomes after post-operative radiotherapy for breast cancer patients presenting with ipsilateral supraclavicular metastasis: considerations on the cranial border of irradiation field
Tác giả: Xiaofang Wang, Xingxing Chen, Xiaomao Guo, Jinli Ma, Xin Mei, Jin Meng, Zhimin Shao, Wei Shi, Zhaozhi Yang, Xiaoli Yu, Li Zhang, Xiaomeng Zhang, Zhen Zhang
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  333.822
 
Efficacy and feasibility of neoadjuvant pembrolizumab plus chemotherapy for early-stage triple-negative and estrogen receptor low, HER2-negative breast cancer: a Japanese single-institution real
Tác giả: Yosuke Aoyama, Yukinori Ozaki, Mari Hosonaga, Ippei Fukada, Fumikata Hara, Takayuki Kobayashi, Toshimi Takano, Takayuki Ueno, Rika Kizawa, Jun Masuda, Saori Kawai, Mami Kurata, Tetsuyo Maeda, Kazuyo Yoshida, Nami Yamashita, Meiko Nishimura
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  003.0285
 
Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients
Tác giả: Kadri Altundag
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  546.752
 
Identifying subgroups of ypN1 breast cancer patients who may exempt from axillary lymph node dissection after neoadjuvant chemotherapy: insights from a large cohort study
Tác giả: Peinan Liu, Dandan Liu, Xiaobin Ma, Huafeng Kang, Meng Wang, Changying Zhao, Yumeng Wei, Xingyu Liu, Hanxiao Cui, Xuyan Zhao, Lidan Chang, Shuai Lin, Hao Wu
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  070.48346
 
Pembrolizumab added to neoadjuvant chemotherapy may improve pathological complete response in androgen-receptor positive and low tumor-infiltrating lymphocytes triple-negative breast cancer patients
Tác giả: Kadri Altundag
Xuất bản: Japan: Breast cancer (Tokyo, Japan , 2025
Bộ sưu tập: NCBI
ddc:  153.1522
 

Truy cập nhanh danh mục